[BOOK][B] Tillit–det nordiska guldet
U Andreasson - 2017 - books.google.com
Rapporten handlar om social tillit i de nordiska samhällena. Norden har högst nivåer av
social tillit i världen. Detta gynnar såväl samhällsekonomin som individer och samhället i dess …
social tillit i världen. Detta gynnar såväl samhällsekonomin som individer och samhället i dess …
CSF biomarker variability in the Alzheimer's Association quality control program
N Mattsson, U Andreasson, S Persson… - Alzheimer's & …, 2013 - Wiley Online Library
Background The cerebrospinal fluid (CSF) biomarkers amyloid beta 1–42, total tau, and
phosphorylated tau are used increasingly for Alzheimer's disease (AD) research and patient …
phosphorylated tau are used increasingly for Alzheimer's disease (AD) research and patient …
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
B Olsson, R Lautner, U Andreasson, A Öhrfelt… - The Lancet …, 2016 - thelancet.com
Background Alzheimer's disease biomarkers are important for early diagnosis in routine
clinical practice and research. Three core CSF biomarkers for the diagnosis of Alzheimer's …
clinical practice and research. Three core CSF biomarkers for the diagnosis of Alzheimer's …
Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease
N Mattsson, U Andreasson, H Zetterberg… - JAMA …, 2017 - jamanetwork.com
Importance Existing cerebrospinal fluid (CSF) or imaging (tau positron emission tomography)
biomarkers for Alzheimer disease (AD) are invasive or expensive. Biomarkers based on …
biomarkers for Alzheimer disease (AD) are invasive or expensive. Biomarkers based on …
Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and …
Background: Neuronal damage is the morphological substrate of persisting neurological
disability. Neurofilaments (Nf) are specific cytoskeletal proteins of neurons and their …
disability. Neurofilaments (Nf) are specific cytoskeletal proteins of neurons and their …
Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis
…, JC Alvarez-Cermeño, U Andreasson… - JAMA …, 2019 - jamanetwork.com
Importance Neurofilament light protein (NfL) is elevated in cerebrospinal fluid (CSF) of a
number of neurological conditions compared with healthy controls (HC) and is a candidate …
number of neurological conditions compared with healthy controls (HC) and is a candidate …
Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease
N Mattsson, NC Cullen, U Andreasson… - JAMA …, 2019 - jamanetwork.com
Importance Plasma neurofilament light (NfL) has been suggested as a noninvasive
biomarker to monitor neurodegeneration in Alzheimer disease (AD), but studies are lacking. …
biomarker to monitor neurodegeneration in Alzheimer disease (AD), but studies are lacking. …
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
N Mattsson, U Andreasson, S Persson… - Alzheimer's & …, 2011 - Wiley Online Library
Background The cerebrospinal fluid (CSF) biomarkers amyloid β (Aβ)‐42, total‐tau (T‐tau),
and phosphorylated‐tau (P‐tau) demonstrate good diagnostic accuracy for Alzheimer's …
and phosphorylated‐tau (P‐tau) demonstrate good diagnostic accuracy for Alzheimer's …
[HTML][HTML] A practical guide to immunoassay method validation
U Andreasson, A Perret-Liaudet… - Frontiers in …, 2015 - frontiersin.org
Biochemical markers have a central position in the diagnosis and management of patients
in clinical medicine, and also in clinical research and drug development, also for brain …
in clinical medicine, and also in clinical research and drug development, also for brain …
Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders
…, A Öhrfelt, R Constantinescu, U Andreasson… - Archives of …, 2012 - jamanetwork.com
Objective To assess the ability of 5 cerebrospinal fluid (CSF) biomarkers to differentiate
between common dementia and parkinsonian disorders. Design A cross-sectional, clinic-based …
between common dementia and parkinsonian disorders. Design A cross-sectional, clinic-based …